Top Markets
Coin of the day
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Rang in Aktien #3532
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Aktienkurs
$4.64
Marktkapitalisierung
$5.17B
Veränderung (1 Tag)
0.34%
Veränderung (1 Jahr)
-37.46%
Land
CN
Handel Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Kategorie

Kursverlauf für Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Höchster Schlusskurs: $4.97 am 2026-08-01

Niedrigster Schlusskurs: $1.19 am 2009-09-01
Kursverlauf der Aktie von Shenzhen Salubris Pharmaceuticals Co., Ltd. von 2009 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -13.99%
2025 80.15%
2024 -0.06%
2023 -1.96%
2022 6.35%
2021 1.19%
2020 61.60%
2019 -18.68%
2018 -47.95%
2017 49.36%
2016 -11.86%
2015 30.44%
2014 5.05%
2013 45.58%
2012 57.04%
2011 -36.22%
2010 64.27%
2009 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$371.13 -21.75%
US
$190.56 -38.45%
FR
$162.88 24.70%
JP
$189.94 24.49%
US
$76.21 -6.15%
CH